Navigation Links
The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
Date:6/19/2008

The results of a major international clinical trial coordinated by the Montreal Heart Institute were reported today in the New England Journal of Medicine. The Atrial Fibrillation and Congestive Heart Failure Trial (AF-CHF) was a prospective, multicentre project involving patients with heart failure and atrial fibrillation. Heart failure is an important cause of death in the population and associated atrial fibrillation (a very common heart rhythm disorder) further increases the risks. The trial was launched in 2001 and enrolled 1,376 patients at 123 hospital sites in North America, South America, Europe and Israel. The project's goal was to improve treatment with the objective of reducing mortality and morbidity linked with atrial fibrillation and heart failure. Made possible by a grant of more than $6.5 million from the Canadian Institutes of Health Research (CIHR), this study was directed by Dr. Denis Roy, a cardiologist at the Montreal Heart Institute (MHI) and Chair of the Department of Medicine at the Universit de Montral, in collaboration with Dr. Mario Talajic, also a cardiologist at the MHI, and several Canadian researchers and international experts who contributed to this large-scale research project.

Methodology

Between May 2001 and June 2005, the 1,376 patients were randomly assigned to a rhythm-control strategy (where patients received electrical shocks and medication to suppress the abnormal rhythm) or a more simpler strategy of rate-control (where two common drugs, beta-blockers and digitalis, are used to prevent rapid heart rates with no specific efforts to regularize the rhythm). The primary endpoint of the study was cardiovascular mortality. Data management and analysis were performed at the Montreal Heart Institute Coordinating Center (MHICC).

Rate-control as effective as rhythm-control

The intention-to-treat analysis revealed no difference in the primary endpoint between the two groups.
'/>"/>

Contact: Valrie Gonzalo
gonzalo@videotron.ca
514-626-6976
University of Montreal
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress
2. Worrell Inc. Acquires Gad Shaanan Design Operations in Montreal and San Diego
3. The Montreal Childrens Hospital of the MUHC begins search for causes of autism
4. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
5. Drug for cluster headaches may cause heart problems
6. Use of certain lipid measures not more effective in predicting coronary heart disease
7. Restricting Blood Flow May Help Heart Bypass Patients
8. Urban Smog Tough on Young Adults Hearts
9. Stanford study highlights cost-effective method of lowering heart disease risks
10. Vitamin Es lack of heart benefit linked to dosage
11. Drug That Lowers Resting Heart Rate Being Tested
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 TayganPoint Consulting Group, ... that President and co-founder John Cassimatis was named ... Winners for 2014, recognizing the region’s top healthcare ... emerging executive of the year. , The Innovation ... sciences that continue to shape the medical industry ...
(Date:9/18/2014)... breeding grounds for microbes -- don,t worry, it,s a ... years, not all microbes are bad. Many active enzymes ... beneficial to humans as an important part of our ... , Candida albicans , an opportunistic yeast pathogen ... doesn,t damage our healthy personal ecosystem. However, when our ...
(Date:9/18/2014)... effect of guidelines recommending that elderly men should not ... at best," according to a new study led by ... a research letter online in JAMA Internal Medicine ... antigen to test for prostate cancer., "We found ... routine screening of elderly men in particular has been ...
(Date:9/18/2014)... York (PRWEB) September 18, 2014 ... to mount in U.S. courts, Bernstein Liebhard LLP ... that the U.S. Food & Drug Administration (FDA) ... that, if implemented, could greatly reduce their use. ... and Urologic Drug Advisory Committee, and the Drug ...
(Date:9/18/2014)... 18, 2014 (HealthDay News) -- Teens and young adults ... a job that provides them with greater responsibility and ... new study. "We found that having a mentor ... the study,s lead author, Steve McDonald, an associate professor ... a university news release. In conducting the ...
Breaking Medicine News(10 mins):Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3Health News:Professional recommendations against routine prostate cancer screening have little effect 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 3Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 4Health News: Mentors May Steer Young People Toward More Rewarding Careers 2
... The University of Houston Center for Drug and Social Policy ... the National Institutes of Health to study the long-term consequences ... will be awarded over the next four years. , ... years ago with 160 gang members in west San Antonio," ...
... Tips and Products to Pamper Tired TootsiesBETHESDA, Md., Feb. 12 ... decadent pampering for countless men and women. While the old ... stomach" may still hold true, another body part is gaining ... American Podiatric Medical Association (APMA) survey revealed 84 percent of ...
... Wildcatter Ranch, warriors to utilize natural surroundings to ... journey to heal-JACKSONVILLE, Fla., Feb. 12 Wounded ... that they will host 16 wounded warriors as ... post traumatic stress disorder (PTSD). Project Odyssey ...
... with special health care needs often do not get ... of a recent study by researchers at Wake Forest ... with private insurance have more unmet respite care needs ... families or caregivers who need respite care the most ...
... its kind Global,Consumer Study is here! Never before ... trends in 15 countries. ISPA, working with Research,International, ... Italy, Japan, Russia, Singapore, Spain, Thailand, UK and USA,and ... why people,spa in the 2008 Global Consumer Study. ...
... a key role in the prevention and treatment of ... Endothelial cells line the blood vessels and are critical ... , Researchers at the Centenary Institute have discovered ... cells. , Professor Jenny Gamble, Head of ...
Cached Medicine News:Health News:Gang researchers at UH examine health, consequences of long-term gang 2Health News:American Podiatric Medical Association Helps Americans 'Love' Their Feet This Valentine's Day 2Health News:American Podiatric Medical Association Helps Americans 'Love' Their Feet This Valentine's Day 3Health News:Wounded Warrior Project's Project Odyssey Aims to Teach Coping Skills for Combating Post-Traumatic Stress in Wounded Warriors 2Health News:Wounded Warrior Project's Project Odyssey Aims to Teach Coping Skills for Combating Post-Traumatic Stress in Wounded Warriors 3Health News:Caregivers not receiving the help they need, study shows 2Health News:Caregivers not receiving the help they need, study shows 3Health News:Worldwide, Stress is the No.1 Reason People Spa 2Health News:Deciphering the body's healing secrets 2
(Date:9/18/2014)... SAN DIEGO , Sept. 18, 2014 /PRNewswire/ ... today announced that the U.S. Food and Drug ... patient enrollment and dosing of PEGPH20 in SWOG,s ... is designed to evaluate Halozyme,s investigational drug PEGPH20 ... FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic ...
(Date:9/18/2014)... and MELBOURNE, Australia , Sept. ... Biopharma today announced the appointments of Dr. Ashraf ... D.V.M ., M.S., to its Board of Directors. Dr. ... Affairs Finance at Genentech and Chief Financial Officer for ... as Vice President and Global Head of Business Development ...
(Date:9/18/2014)... SYDNEY , Sept. 18, 2014 Australian ... an important US trial of its MiStat™ prostate cancer ... Administration (FDA) regulatory approval upon completion. Minomic,s ... identifying the presence of a proprietary biomarker known as ... surface of prostate cancer cells. Researchers ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... , SUNNYVALE, Calif. , Feb 11 ... second fiscal quarter ended December 31, 2009 . , Upon ... ended December 31, 2009 , the company began recognizing revenue under ... April 2009 . Total revenue recognized under GAAP in our most ...
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported sales ... December 31, 2009 . , Highlights: , ... Nine month cash flow provided by operations exceeded $4,882,000 ... six month period over the prior six months. , ...
Cached Medicine Technology:Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 2Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 3Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 4Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 5Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 6Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 7Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 8Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 9Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 10Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 11Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 12Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 13Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 14Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 15Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 16Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 17Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 18Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 19Mesa Labs Reports Quarterly Sales and Earnings 2Mesa Labs Reports Quarterly Sales and Earnings 3Mesa Labs Reports Quarterly Sales and Earnings 4Mesa Labs Reports Quarterly Sales and Earnings 5Mesa Labs Reports Quarterly Sales and Earnings 6
... is designed to easily couple with ... coupling eliminates clumsy time consuming delays. ... well. Dorniers patented isocentric locating arm ... simple using the Dornier Relax+ table, ...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
The latex free, hydrophilic Self-Cath Plus is designed for single use, intermittent self-catheterization. The unique hydrophilic coating activates immediately upon exposure to water for fast, clean...
... The Self-Cath Closed System is ... a method for safe, simple catheterization ... urinary tract infections. It includes ... The new EasyOff tear tab ...
Medicine Products: